Medical or invasive therapy for GERD: An acidulous analysis

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

This review critically appraises the evidence on the benefits and costs of the available treatments for gastroesophageal reflux disease (GERD) and concludes that antireflux surgery has no clear advantages over medical therapy for efficacy of healing, prevention of complications, safety, side effects, and cost. Indeed, medical therapy is safer and, probably, more cost-effective. Compared with medically treated patients, those who have successful fundoplication may be less inconvenienced by GERD because they are less likely to need to take pills on a daily basis. The patient and physician must judge whether that benefit justifies the risks of surgery for a benign condition. There is not yet sufficient data available on the endoscopic antireflux procedures to make meaningful conclusions regarding their safety and efficacy.

Original languageEnglish (US)
Pages (from-to)81-88
Number of pages8
JournalClinical Gastroenterology and Hepatology
Volume1
Issue number2
DOIs
StatePublished - Mar 1 2003

Fingerprint

Gastroesophageal Reflux
Safety
Costs and Cost Analysis
Fundoplication
Cost-Benefit Analysis
Therapeutics
Physicians

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Medical or invasive therapy for GERD : An acidulous analysis. / Spechler, Stuart Jon.

In: Clinical Gastroenterology and Hepatology, Vol. 1, No. 2, 01.03.2003, p. 81-88.

Research output: Contribution to journalArticle

@article{bf93bfbc0c9642b095fc211d3b0bda4b,
title = "Medical or invasive therapy for GERD: An acidulous analysis",
abstract = "This review critically appraises the evidence on the benefits and costs of the available treatments for gastroesophageal reflux disease (GERD) and concludes that antireflux surgery has no clear advantages over medical therapy for efficacy of healing, prevention of complications, safety, side effects, and cost. Indeed, medical therapy is safer and, probably, more cost-effective. Compared with medically treated patients, those who have successful fundoplication may be less inconvenienced by GERD because they are less likely to need to take pills on a daily basis. The patient and physician must judge whether that benefit justifies the risks of surgery for a benign condition. There is not yet sufficient data available on the endoscopic antireflux procedures to make meaningful conclusions regarding their safety and efficacy.",
author = "Spechler, {Stuart Jon}",
year = "2003",
month = "3",
day = "1",
doi = "10.1053/cgh.2003.50013",
language = "English (US)",
volume = "1",
pages = "81--88",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Medical or invasive therapy for GERD

T2 - An acidulous analysis

AU - Spechler, Stuart Jon

PY - 2003/3/1

Y1 - 2003/3/1

N2 - This review critically appraises the evidence on the benefits and costs of the available treatments for gastroesophageal reflux disease (GERD) and concludes that antireflux surgery has no clear advantages over medical therapy for efficacy of healing, prevention of complications, safety, side effects, and cost. Indeed, medical therapy is safer and, probably, more cost-effective. Compared with medically treated patients, those who have successful fundoplication may be less inconvenienced by GERD because they are less likely to need to take pills on a daily basis. The patient and physician must judge whether that benefit justifies the risks of surgery for a benign condition. There is not yet sufficient data available on the endoscopic antireflux procedures to make meaningful conclusions regarding their safety and efficacy.

AB - This review critically appraises the evidence on the benefits and costs of the available treatments for gastroesophageal reflux disease (GERD) and concludes that antireflux surgery has no clear advantages over medical therapy for efficacy of healing, prevention of complications, safety, side effects, and cost. Indeed, medical therapy is safer and, probably, more cost-effective. Compared with medically treated patients, those who have successful fundoplication may be less inconvenienced by GERD because they are less likely to need to take pills on a daily basis. The patient and physician must judge whether that benefit justifies the risks of surgery for a benign condition. There is not yet sufficient data available on the endoscopic antireflux procedures to make meaningful conclusions regarding their safety and efficacy.

UR - http://www.scopus.com/inward/record.url?scp=0141734063&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141734063&partnerID=8YFLogxK

U2 - 10.1053/cgh.2003.50013

DO - 10.1053/cgh.2003.50013

M3 - Article

C2 - 15017499

AN - SCOPUS:0141734063

VL - 1

SP - 81

EP - 88

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

IS - 2

ER -